BackNykode Therapeutics AS Overview

Nykode Therapeutics AS Current Assets

Nykode Therapeutics AS's current assets is $48M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$48.47M
↓ 33.38% YoYΔ $-24.29M vs prior year quarter

Peer trimmed avg / median

Loading

Nykode Therapeutics AS Current Assets History

Loading

Nykode Therapeutics AS vs. peers: Current Assets Comparison

Loading

Nykode Therapeutics AS Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nykode Therapeutics AS (NYKD.OL) FAQ

Nykode Therapeutics AS posts a current assets of $48M as of June 2026. That compares with $73M in the prior-year period — down 33.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Nykode Therapeutics AS's current assets was $73M. The latest reading is $48M — a 33.4% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Nykode Therapeutics AS's financial statement story. At $48M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NYKD.OL's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Nykode Therapeutics AS's other metric pages and overview cover the third.

Judging Nykode Therapeutics AS against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current assets easier to interpret. Start with $48M here, then scan peer and history charts to see if the gap is persistent.